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Abstract
Background: As minimally invasive cardiac and vascular procedures are on the rise, the incidence of iatrogenic
acute aortic dissection (IAAD) will increase. Cardiovascular professionals should be aware about the risk factors,
means of prevention and best management options for IAAD in the perioperative setting.
Case presentation: We present the successful clinical management of a complicated case of IAAD after minimally
invasive aortic valve replacement.
Conclusion: High index of suspicion is required for prompt diagnosis of IAAD; collaboration of the whole
perioperative team is imperative for management of this catastrophe.
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Background
Iatrogenic acute aortic dissection (IAAD) is a fatal compli-
cation that can occur after open cardiac surgery, complex
percutaneous coronary intervention (PCI), thoracic endo-
vascular aortic aneurysm repair (TEVAR) and transaortic
valve replacement (TAVR). As minimally invasive proce-
dures are on the rise, the incidence of IAAD will increase.
IAAD carries high mortality and represents a huge
challenge to all cardiovascular professionals including
cardiac surgeons who encounter this clinical scenario [1].
Here we present the successful clinical management of a
case of IAAD after minimally invasive aortic valve replace-
ment (AVR). We will review the literature for incidence,
risk factors, diagnosis and management of IAAD in open
cardiac surgery, PCI, TEVAR and TAVR.
Case presentation
Sixty-seven years old female patient with history of atypical
chest pain, exertional dyspnea, asthma and hypothyroidism
was diagnosed with aortic insufficiency. Her preoperative
echocardiography findings were dilated aortic root (3.7 cm),
mild left ventricular hypertrophy and ejection fraction
(70 %). Evaluation by cardiac catheterization revealed severe
aortic regurge and normal coronary arteries. An 8 cm
median sternotomy was performed. The distal ascending
aorta was cannulated at blood pressure of 100 mmHg
systolic and cardiopulmonary bypass (CPB) was initiated
with good flow and pressures in the cannula. The surgeon
noticed a hematoma around the cannulation site. With the
aid of Transesophageal echocardiography (TEE) done by
the anesthesiologist, diagnosis of a type A acute aortic
dissection was made, that was extending to the aortic root
and the descending aorta (Fig. 1). CPB was terminated
without any significant event, and right common femoral
artery was cannulated for alternate route of CPB. The
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sternotomy incision was extended to a full sternotomy.
Cooling for 48 min to 18 degrees Centigrade nasopharyn-
geal temperature was achieved for deep hypothermic
circulatory arrest. Bentall procedure with a composite
Carpentier-Edwards Perimount 23 mm tissue valve and a
28 mm Hemashield graft was performed. Circulation was
resumed and patient was rewarmed. Both coronary arteries
buttons were attempted but failed due to frail intima at the
coronary ostia. Left main coronary artery was reimplanted
via a Cabrol procedure with an 8 mm Hemashield graft. By-
pass of the right coronary artery with reverse saphenous
vein graft was also done. We weaned the patient from CPB
but there was progressive dilatation of the right ventricle
and left ventricular dysfunction, so we were concerned with
the graft for the left main coronary artery. We went back
on CPB to perform bypasses to the left anterior descending
artery and the obtuse marginal artery using reverse saphe-
nous vein grafts. Then, we weaned the patient from CPB
again with difficulty on high doses of inotropic support.
Due to long CPB time (336 minutes), the team decided to
support the patient with venoarterial extracorporeal mem-
brane oxygenation (VA ECMO) by re-cannulating the right
common femoral artery and vein. The chest was left open
at the end of the procedure due to cardiac edema and dis-
tension. The patient was transferred to the ICU in ex-
tremely critical condition. The cross-clamp time was
70 min and circulatory arrest time was 17 min. The patient
required massive blood transfusion (140 units of blood
products) in the perioperative period. The chest wall was
closed 3 days postoperative and was kept on ECMO sup-
port for 17 days. The patient had a vigorous postoperative
course complicated by cardiac tamponade that required
multiple bedside washouts. She also suffered from subacute
right middle cerebral artery territory infarct that developed
intraoperative with residual left sided hemiparesis. She also
had prolonged intubation due to failure of multiple spon-
taneous breathing trials and she required tracheostomy on
the twentieth postoperative day. Her last echocardiography
findings before discharge were normal right and left ven-
tricular sizes with mild to moderate systolic dysfunction
(Ejection fraction: 30–35 %). The patient was discharged on
the 35th postoperative day and she is continuing her re-
habilitation and following up. One year later, she is totally
independent and in good health, and her echocardiog-
raphy showed normal ejection fraction.
Risk factors of IAAD
IAAD after cardiac surgery is a rare and devastating com-
plication. Here we present a case of successful management
after very complicated clinical course. Cannulation of the
ascending aorta for CPB was first announced in 1959 [2],
and since then, IAAD continues to be a fearful fatal compli-
cation that turns routine open cardiac surgery into a major
clinical challenge to the team who faces it.
Our patient had three risk factors: hypertension, aortic
regurgitation and thinned dilated aorta, which we believe
predisposed her to IAAD. In a recent editorial in which
IAAD was described as a perfect storm, the author sug-
gested to consider replacement of the ascending aorta in
patients having these three risk factors [1].
Other risk factors for IAAD include old age, known ath-
erosclerotic disease and previous CABG surgery [3]. In
addition, high and low blood pressures during insertion of
the aortic cannula play a role in the development of IAAD
[4]. Very low blood pressure renders the aortic wall
unsupported during cannulation with increased liability to
dissection.
Recent classification for IAAD in cardiac surgery
Recently, in a multicenter study by Stanger et al. [5],
IAAD following cardiac surgery is classified into intraop-
erative, early postoperative (symptoms of aortic dissection
within 30 days of surgery with high risk of aortic rupture
and intraoperative mortality) and late postoperative (after
Fig. 1 Diagnosis of IAAD by TEE. TEE Mid Esophageal Ascending Aorta Long Axis view. a Before aortic cannulation; b After aortic cannulation
showing intimal flap on the anterior aortic wall at the sinotubular junction with the development of true and false aortic lumens and extending
antegrade and retrograde: Type A acute aortic dissection (Yellow Arrow)
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30 days from cardiac surgery). They further classified late
postoperative IAAD into acute (patients required inter-
vention within 2 weeks of symptoms) and chronic (late in-
cidental finding of dissection with no acute symptoms,
candidates for elective surgery) (Table 1).
Incidence and common entry sites of IAAD
Literature shows the incidence of IAAD to be 0.12–
0.23 %; mortality rates range from 20 to 43 % [6, 7],
with decreased rates when IAAD is diagnosed intraopera-
tively, and its extension is limited to the aortic arch [8].
Most dissection sites mentioned in the literature after
open cardiac surgery were related to aortic cannulation,
aortic cross-clamping, aortotomy, vein anastomosis
during CABG, the cardioplegia cannula, direct aortic
injury and injury related to flow of the bypass to the
aortic arch or descending thoracic aorta [5, 9–12].
Reviewing the literature in 3 single center and 1 multi-
center studies showed nearly the same trends in sites of
IAAD over that last 35 years (Table 1) [5, 10–12]. In the
majority of cases, the site of dissection in intraoperative
cases was the cannulation territory which is consistent
with our case.
Table 1 Trends in sites of iatrogenic aortic dissection after cardiac surgery in literature
Gott et al. [10]
(N = 27/11,145)
1982–1988
Still et al. [11]
(N = 24/14,877)
1980–1990
Leontyev et al. [12]
(N = 36/55,279)
1995–2010




(N = 27) (N = 20) (N = 31) (N = 24)
Aortic cannulation 10 (37 %)a 10 (50 %)a 12 (38 %)a 7 (29.1 %)a
Cardioplegia cannula 5 (18.5 %) 0 (0 %) 7 (22.6 %) 4 (16.7 %)
Aortic cross-clamp 4 (14.8 %) 8 (40 %) 4 (12.9 %) 7 (29.1 %)a
Proximal anastomosis 2 (7.4 %) 1 (5 %) 1 (3.2 %) 5 (20.8 %)
Direct aortic injury 0 (0 %) 1 (5 %) 0 (0 %) 0 (0 %)
Unknown 2 (7.4 %) 0 (0 %) 5 (16.1 %) 1 (4.2 %)
2- Early Postoperative:
(N = 4) (N = 5) (N = 12)
Aortic cannulation 3 (75 %)a 2 (40 %)a 0 (0 %)
Cardioplegia cannula 0 (0 %) 0 (0 %) 1 (8.3 %)
Aortic cross-clamp 1 (25 %) 0 (0 %) 1 (8.3 %)
Proximal anastomosis 0 (0 %) 1 (20 %) 8 (66.7 %)a
Aortotomy 0 (0 %) 0 (0 %) 2 (16.7 %)
Unknown 0 (0 %) 2 (40 %)a 0 (0 %)
3- Late: Postoperative
a) Acute (N = 44)
Aortic cannulation 1 (2.2 %)
Cardioplegia cannula 0 (0 %)
Aortic cross-clamp 2 (4.5 %)
Proximal anastomosis 10 (22.7 %)
Aortotomy 24 (54.5 %)a
Unknown 7 (15.9 %)
b) Chronic (N = 23)
Aortic cannulation 2 (8.7 %)
Cardioplegia cannula 0 (0 %)
Aortic cross-clamp 0 (0 %)
Proximal anastomosis 9 (39.1 %)a
Aortotomy 11 (47.8 %)
Unknown 1 (4.3 %)
aRepresents highest incidence in each category within every study
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Prevention and management of IAAD
Role of surgeons
Aortic cannulation is the single most important step in
cardiac surgery and prevention of IAAD is the best treat-
ment strategy. Surgeons should be extremely cautious
during aortic cannulation, clamp application and re-
moval especially in patients with risk factors for IAAD.
Cannulation purse‑string sutures should be taken with
deep partial or full thickness bites. Surgeons should also
avoid torsion and proximity of the partial‑occlusion
clamp to the aortic cannula [13].
IAAD diagnosis requires high index of suspicion and it
depends primarily on visualization and imaging. Intraop-
erative diagnosis is achieved by visualization of a bluish
discoloration and dilatation of the aorta [9]. Still et al. [11]
differentiated a subadventitial hematoma from IAAD; the
subadventitial hematoma is usually small, enlarges slowly,
stops enlarging after initiation of bypass, soft to palpation
and can be decompressed by incising the aortic surface.
IAAD, on the other hand, may involve the entire aorta or
part of it, giving it a tense, dilated bluish discoloration,
and bleeds rapidly on incision of the adventitial surface.
Once IAAD is confirmed, the surgeon has to secure an
alternative peripheral site of cannulation and ensures that
the blood flow is through the true aortic lumen.
Role of anesthesiologists
Anesthesiologists are encouraged to routinely examine
the cannulation site after insertion and removal of the
aortic cannula as well as the other previously reported
possible entry sites of dissection whenever possible using
TEE. Routine use of TEE aids in the rapid diagnosis and
the prompt management of IAAD with a sensitivity of
98 % and specificity of 95 %. TEE also differentiates
dissection from subadventitial hematoma. However,
visualization of IAAD by TEE in the distal ascending
aorta and proximal arch may be limited due to the inter-
position of tracheal air between the ultrasonic probe and
the aorta, and may require an epiaortic echocardio-
graphic probe [6, 14, 15]. Moreover, epiaortic scanning
can be used when there is a contraindication for the use
of TEE [16]. Once IAAD is confirmed and until an alter-
nate cannulation site is secured, the anesthesiologists
have an important role to support the circulation during
the transition from CPB to spontaneous circulation in
order to maintain critical organs perfusion.
Role of perfusionist
Communication between the perfusionist and the surgeon
is mandatory during the test transfusion to ensure proper
placement of the aortic cannula. The pump should be
started slowly, while the arterial line pressure is being
checked for any pressure rise denoting obstruction. Aortic
dissection is among one of the causes of abrupt increase
in the arterial pressure line and needs to be excluded. It is
advisable for the perfusionist to reduce the pump flow
(0.5–1 L/min) during insertion or removal of the aortic
cannula [17].
After diagnosis of IAAD, the underlying cause should be
corrected and the management plan should be changed
aiming at repair of the dissection. In cases with small in-
timal tear, simple primary repair could be achieved [18].
In our case, we had to initiate CPB through peripheral
cannulation and performed hypothermic circulatory arrest
for repair of the dissection. The rate of institution of
hypothermic circulatory arrest for repair of IAAD men-
tioned in the literature ranged 50–95 % [5, 10–12].
Ruchat et al. [9] mentioned that cerebral malperfusion
is one of the unfavorable outcomes of IAAD that may be
due to extension of the dissection beyond the aortic
arch. In their study, two of seven patients who experi-
enced IAAD died of hypoxic brain insult. Prompt intra-
operative diagnosis and management of IAAD may
prevent this sequel. In another study, stroke was re-
ported in 27 of 103 patients with IAAD [5]. Our patient
developed right middle cerebral artery infarction that
was most probably due to cerebral hypoperfusion from
severe hemodynamic instability or embolism, but was
not explained to be due to vascular dissection neither by
intraoperative evidence through direct visualization of
the arch vessels or cerebral monitoring, nor by postoper-
ative imaging using carotid Doppler and MRA.
Our patient had a complicated postoperative course in
the ICU, including bleeding and recurrent cardiac tam-
ponade. After one year follow up, our patient, is in good
health owing to the team approach.
ECMO support and coagulation management
The use of ECMO as a salvage modality for cardiogenic
shock, specifically post-cardiotomy cardiogenic shock,
may offer advantages over conventional medical therap-
ies [19, 20]. The benefit of mechanical support providing
improved cardiac output without the negative hypoper-
fusion consequences, led to the proactive initiation of
VA ECMO support. Squiers et al. [21] concluded that
VA ECMO offers certain advantage in rare instances of
postcardiotomy shock, in addition to other studies that
showed excellent long-term survival in patients surviving
the acute perioperative period.
Our patient required transfusion of 140 units of blood
and blood products in a very short period of time. Mas-
sively transfused patients have improved survival when re-
ceiving a high fresh frozen plasma:RBC and platelet:RBC
ratio [22]. As such, we utilize point of care testing rota-
tional thromboelastometry (ROTEM) perioperative in our
patients, which leads to an increase in fresh frozen plasma
and platelet to RBC transfusion ratio, that is consequently
associated with improved survival [22].
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Our center utilizes Extracorporeal Life Support
Organization (ELSO) guidelines for anticoagulation
and therapeutic management of unfractionated heparin
(UNFH) during mechanical support. [20] We utilize an
ECMO circuit with a biocompatible coated surface that
provides a significant benefit in patients with massive coa-
gulopathic bleeding, as it allows the delay of anticoagulation
at the start of extracorporeal life support (ECLS).
The activated clotting time (ACT) is a universally
accepted, and a readily available intraoperative point of
care test to assess and dose UNFH. However, post-
operative therapeutic anticoagulation, will be influenced
by many factors including urine output, renal replacement
therapy, platelet administration, and underlying coagula-
tion changes. Additionally, the ACT test will be affected
by postoperative factors such as thrombocytopenia, and
smaller percent changes in individual clotting cascade
factors than the activated partial thromboplastin time
(APTT). A recent study in pediatric ECLS patients
showed that the APTT (clinical laboratory and POC) cor-
related to UNFH dose better than ACT and, as expected
the APTT and UNFH dose correlation improved with in-
creasing patient age [23]. As recommended per ELSO
guidelines, using one method of UNFH activity alone is
considered insufficient today, and yet an array of too many
tests for UNFH therapy, multiple times per day, could
provide possible confusion to ECLS team members [20].
Our center therefore monitors UNFH activity during the
postoperative course with the more sensitive APTT test,
to maintain a therapeutic level, and supplementation of
ROTEM tests as needed.
IAAD in other minimally invasive cardiovascular procedures
IAAD can present with other cardiovascular procedures:
during diagnostic and therapeutic coronary artery inter-
vention, TEVAR and TAVR. The clinical presentation
and the management vary widely.
IAAD during coronary artery intervention
In the Catheterization Lab, IAAD may occur during
diagnostic and therapeutic PCI. The incidence of IAAD
in cardiac catheterization is less than 0.1 %. It may in-
volve the coronary arteries and/or the aorta. National,
Heart, Lung and Blood Institute (NHLBI) classified coron-
ary artery dissection to 6 types, none of which involved
the aortic root [24]. A simplified classification for this type
of dissection was mentioned by Eshtehardi et al. [25]: type
I (localized dissection in the coronary arteries), type II
(extension of dissection into major coronary branches),
and type III (extension of the dissection into the aortic
root). Cardiac surgeons will manage emergency cardiac sur-
geries in a small fraction of cases of cardiac catheterization
complicated by IAAD. Current data on incidence and the
clinical outcome of IAAD in cardiac catheterization is
limited. In multicenter study the incidence of IAAD was
0.062 %, of those involving the coronary tree was 0.039 %
with higher incidence in therapeutic than in diagnostic pro-
cedures. The operator expertise and the use of guiding
wires in complex procedures are suggested risk factors
leading to IAAD after PCI [26].
In a study by Leontyev et al. [12], 12 out of 135,262
patients developed IAAD after cardiac catheterization;
all patients underwent surgical intervention with 30 day
mortality of 50 % denoting high mortality in this group
of patients. In another registry, only 3 patients out of 74
patients with IAAD after PCI were referred to surgery.
The rest of the patients were managed either conserva-
tively or by PCI [26]. This might be attributed to differ-
ence in local practice and/or the type and extent of
dissection. In patients with retrograde dissection not in-
volving the coronary arteries, conservative management
may be attempted together with close patient monitor-
ing for possible surgical intervention. On the other hand,
antegrade dissections usually require endovascular or
surgical management [26].
IAAD during TEVAR
Minimal invasive techniques have changed clinical prac-
tice for management of thoracic aortic diseases. TEVAR
is the first choice therapy for most thoracic aortic dis-
ease. IAAD after TEVAR was also reported in the litera-
ture with incidence ranging 1–6.8 % [27, 28]. Several
factors leading to this complication have been proposed:
instrumentation and stent negotiation, underlying aortic
pathology (e.g. aneurysm, ulcer) leading to fragile wall,
oversized grafts, excessive aortic arch angulation and
expanding intramural hematoma [29, 30]. Even with im-
mediate open surgical management to prevent grave out-
comes, mortality rate in the literature is 44–57 % [30].
IAAD during TAVR
With the rapid increase in the number of TAVR cases
around the globe, the association between IAAD and
TAVR is also emerging in the literature. IAAD after TAVR
procedure is mentioned as part of the major vascular com-
plications. The incidence ranges from 0.2 % in the GARY
registry (33 IAAD of 15,964 patients) to 2 % in transapical
TAVR cases in another review [31, 32]. In the PARTNER
trial, there were 3 patients with IAAD out of 419 included
in the trial; however, in the three studies, specific clinical
management of IAAD was not mentioned [33].
Conclusion
IAAD is a dreadful complication that carries high mor-
bidity and mortality. All cardiovascular professionals
should be ready to diagnose and quickly intervene spe-
cially with the increase in numbers and complexity of
minimally invasive procedures.
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